Immunohistochemistry Market

Major Players in the Global Immunohistochemistry Market are Product Launches, Agreements, Partnerships & Collaborations, Acquisitions and Geographic Expansions

The global immunohistochemistry market is consolidated in nature with the top five market players accounting for more than 50% of the global market. F. Hoffmann-La Roche AG (Switzerland), Danaher Corporation (U.S.), Agilent Technologies, Inc. (U.S.), Thermo Fisher Scientific Inc. (U.S.), and Merck Millipore (U.S.) lead the global immunohistochemistry market. Some of the other leading players in this market include Bio-Rad Laboratories, Inc. (U.S.), PerkinElmer, Inc. (U.S.), Abcam plc. (U.K.), Cell Signaling Technology, Inc. (U.S.), and Bio SB Inc. (U.S.).

F. Hoffmann-La Roche AG is one of the leading players in the immunohistochemistry market. It is a research-based healthcare company that provides innovative diagnostic and therapeutic products and services that deliver significant benefits to patients and healthcare professionals. The company provides the top class tissue processing systems with automates and semi-automated features, slide staining systems, and reagents under its product portfolio. The company focuses on R&D activities to deliver more sustainable products and to enhance its service offerings. It invested more than USD 9,713 million in 2015 on its R&D activities. It also focuses on inorganic growth strategy which is evident from the acquisitions and agreements signed during the last couple of years. It acquired Dutalys GmbH (Austia) and Ariosa Diagnostics, Inc. (U.S.) in December 2014 and GeneWEAVE BioSciences, Inc. (U.S.) in August 2015.

Leica Biosystems, a division of Danaher Corporation (U.S.), is one of the major providers of in vitro diagnostic products. Leica Biosystems specializes in the equipment used for immunohistochemistry and consumables. The company’s presence in various industries and diverse geographic presence helps it to reduce the adverse impacts of any one industry or economy on its consolidated financial performance. In 2015, the company has invested USD 1,239.1 million (around 6% of the total revenue) in R&D; this reflects company’s high focus on innovation and development of the new products and technology. Moreover, the company focuses on strengthening its business through acquisitions; this can be inferred by the acquisition of Devicor Medical Products, Inc. (U.S.) in 2014.

Agilent Technologies is a large player in the diagnostics products market, with wide geographical coverage. The company is well-positioned in the IHC market and focuses on developing innovative diagnostic and therapeutic solutions to combat the rise in infectious diseases, genetic disorders, and cancer. In accordance to this, the company established a strong network of research organizations, based in Santa Clara, U.S. and California, U.S., with offices in Europe and Asia. The company focuses on acquisitions as a key growth strategy. In November 2015, Agilent Technologies Inc. acquired Seahorse Bioscience (U.S.), a leader in providing instruments and assay kits for measuring cell metabolism and bioenergetics. Seahorse’s unique technology complements Agilents leading separations and identification solutions. In May 2015, Agilent acquired Cartagenia (Belgium), a leading provider of software and services for clinical genetics and molecular pathology labs. Agilent Technologies also focuses on new and innovative product launches as an important growth strategy to enhance its portfolio of instruments, software, consumables, and services. Between 2015 and 2016, the company launched several new tests that can identify PD-L1 expression levels.

The key strategies adopted by major players in the global immunohistochemistry market are product launches; agreements, partnerships & collaborations; acquisitions; and geographic expansions. In this competitive market, global players aim to maintain their market position through continuous investments in R&D with a focus on developing innovative solutions or enhancing their existing solutions.

Related Reports:

Immunohistochemistry Market by Product (Antibody, Reagent, Kits, Slide Staining System, Tissue Microarray) Application (Diagnostics (Cancer, Cardiovascular, Diabetes, Autoimmune, Infectious Diseases) & Drug Testing) End User - Global Forecast to 2021

Mr. Rohan
Markets and Markets 
UNIT no 802, Tower no. 7, SEZ
Magarpatta city, Hadapsar
Pune, Maharashtra 411013, India

Report Code
BT 4780
Published ON
Nov, 2016
Choose License Type
Request Customization
Speak to Analyst
Speak to Analyst
  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
  • What are the Known and Unknown Adjacencies Impacting the Immunohistochemistry Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
© MarketsandMarkets Research Private Ltd. All rights reserved